信息加载中,请等待...

  • 20231219-Morgan Stanley-China Resources Sanjiu Medical&PharmaAsia Pacific:Risk Reward Update.pdf
  • 20231219-Morgan Stanley-Chinese GrowthTech_Active Fund Flows and Short Interest.pdf
  • 20231219-Morgan Stanley-Global Credit Strategy:All Eyes on Beta.pdf
  • 20231219-Morgan Stanley-Growth On Track; Macro_stability Indicators Remain Benign.pdf
  • 20231220-Morgan Stanley-Global Macro Strategy:December Index Extensions.pdf
  • 20231221-Morgan Stanley-2024 REITOutlook North America:Navigating a Fed Easing Cycle.pdf
  • 20231221-Morgan Stanley-Correction: Looking through the elections.pdf
  • 20231222-Morgan Stanley-Nationwide CPI (Nov): US_style core still high at +2.7%, but weighted median likely to fall below 2%.pdf
  • 20231224-Morgan Stanley-nvestor Presentation.pdf
  • 20231225-Morgan Stanley-Risk Reward Update.pdf
  • 20231226-Goldman Sachs-US Economics Analyst:10 Questions for 2024 (Mericle Phillips) (1).pdf
  • 20231226-Goldman Sachs-US Economics Analyst:10 Questions for 2024 (Mericle Phillips).pdf
  • 20231227-Morgan Stanley-Takeaways from Chongqing Reverse Roadshow.pdf
  • 20231229-Goldman Sachs-China: PBOC continues to focus on monetary policy efficiency at Q4 MPC meeting; we expect policy rate cut in Q1.pdf
  • 20231230-Goldman Sachs-China:Capital outflows accelerated in Q3;we expect slower capital outflows in 2024.pdf
  • 20231231-WHO-Children’s Environmental Health International Initiatives.pdf
  • 20231231-WORLD BANK GROUP-Leveraging Diaspora Finances for Private Capital Mobilization.pdf
  • 20240102-Goldman Sachs-Asia Economics Analyst Ten questions for 2024.pdf
  • 20240102-Goldman Sachs-US Conviction List_Directors’ Cut:January 2024 Update: Top Themes for the Year Ahead.pdf
  • 20240103-McKinsey&Company-The arts in the UK:Seeing the big picture.pdf
1.本站不存储真实文件,仅展示文件信息。
2.用户自主配置内容,包括但不限于文件夹、链接、关联网盘等,不代表本站立场。
3.本站以文本、图片展示内容,无法及时审核其合法性。发现侵权内容,请提供资质及链接给客服,将立即移除。
官网:pan.tpym.cn QQ:851232718